These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Association of the neoadjuvant chemotherapy cycle with survival outcomes in patients with locoregionally advanced nasopharyngeal carcinoma: a propensity-matched analysis. Fangzheng W, Chuner J, Zhimin Y, Quanquan S, Tongxin L, Min X, Peng W, Bin L, Sakamoto M, Yuezhen W, Fengqin Y, Zhenfu F, Yangming J. Oncotarget; 2017 Nov 07; 8(55):94117-94128. PubMed ID: 29212214 [Abstract] [Full Text] [Related]
24. Neoadjuvant Chemotherapy with Fluorouracil plus Nedaplatin or Cisplatin for Locally Advanced Nasopharyngeal Carcinoma: a Retrospective Study. Liu T, Sun Q, Chen J, Li B, Qin W, Wang F, Ye Z, Hu F. J Cancer; 2018 Nov 07; 9(20):3676-3682. PubMed ID: 30405836 [Abstract] [Full Text] [Related]
27. The Clinical Outcomes and Toxicities of Induction Chemotherapy Followed by Concurrent Chemoradiotherapy Plus Adjuvant Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma. Zou R, Yuan JJ, Li Q, Ding JW, Liao B, Tu ZW, Hu RH, Gong D, Hu JL, Zeng L. Front Oncol; 2020 Nov 07; 10():619625. PubMed ID: 33791194 [Abstract] [Full Text] [Related]
28. Phase II study of neoadjuvant carboplatin and paclitaxel followed by radiotherapy and concurrent cisplatin in patients with locoregionally advanced nasopharyngeal carcinoma: therapeutic monitoring with plasma Epstein-Barr virus DNA. Chan AT, Ma BB, Lo YM, Leung SF, Kwan WH, Hui EP, Mok TS, Kam M, Chan LS, Chiu SK, Yu KH, Cheung KY, Lai K, Lai M, Mo F, Yeo W, King A, Johnson PJ, Teo PM, Zee B. J Clin Oncol; 2004 Aug 01; 22(15):3053-60. PubMed ID: 15284255 [Abstract] [Full Text] [Related]
32. A concurrent chemoirradiation with cisplatin followed by adjuvant chemotherapy with ifosfamide, 5-fluorouracil, and leucovorin for stage IV nasopharyngeal carcinoma. Chua DT, Sham JS, Au GK. Head Neck; 2004 Feb 01; 26(2):118-26. PubMed ID: 14762880 [Abstract] [Full Text] [Related]
33. Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma : A matched-pair multicenter analysis of outcomes. Dong YY, Xiang C, Lu JX, Su YX, Pan YF, Cai R, Zhang RJ, He ZK, Liu ML, Huang H, Bai X, Tang HY, Shi YH, Wang Y, Jiang W. Strahlenther Onkol; 2016 Jun 01; 192(6):394-402. PubMed ID: 27215563 [Abstract] [Full Text] [Related]
37. Induction chemotherapy with nedaplatin with 5-FU followed by intensity-modulated radiotherapy concurrent with chemotherapy for locoregionally advanced nasopharyngeal carcinoma. Zheng J, Wang G, Yang GY, Wang D, Luo X, Chen C, Zhang Z, Li Q, Xu W, Li Z, Wang D. Jpn J Clin Oncol; 2010 May 01; 40(5):425-31. PubMed ID: 20085903 [Abstract] [Full Text] [Related]
38. Nimotuzumab combined with concurrent chemoradiotherapy in locally advanced nasopharyngeal carcinoma: a retrospective analysis. Liu ZG, Zhao Y, Tang J, Zhou YJ, Yang WJ, Qiu YF, Wang H. Oncotarget; 2016 Apr 26; 7(17):24429-35. PubMed ID: 27016412 [Abstract] [Full Text] [Related]
39. Induction chemotherapy for locoregionally advanced nasopharyngeal carcinoma. Li WF, Chen L, Sun Y, Ma J. Chin J Cancer; 2016 Nov 15; 35(1):94. PubMed ID: 27846913 [Abstract] [Full Text] [Related]
40. Phase II study: concurrent chemo-radiotherapy in advanced nasopharyngeal carcinoma. Maoleekoonpairoj S, Phromratanapongse P, Puttanuparp S. J Med Assoc Thai; 1997 Dec 15; 80(12):778-84. PubMed ID: 9470331 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]